| Literature DB >> 27151592 |
Jennifer M Hulett1, Jane M Armer2.
Abstract
Objective This is a review of spiritually based interventions (eg, mindfulness-based stress reduction) that utilized psychoneuroimmunological (PNI) outcome measures in breast cancer survivors. Specifically, this review sought to examine the evidence regarding relationships between spiritually based interventions, psychosocial-spiritual outcomes, and biomarker outcomes in breast cancer survivors. Methods A systematic search of 9 online databases was conducted for articles of original research, peer-reviewed, randomized and nonrandomized control trials from 2005-2015. Data were extracted in order to answer selected questions regarding relationships between psychosocial-spiritual and physiological measures utilized in spiritually based interventions. Implications for future spiritually based interventions in breast cancer survivorship are discussed. Results Twenty-two articles were reviewed. Cortisol was the most common PNI biomarker outcome studied. Compared with control groups, intervention groups demonstrated positive mental health outcomes and improved or stable neuroendocrine-immune profiles, although limitations exist. Design methods have improved with regard to increased use of comparison groups compared with previous reviews. There are few spiritually based interventions that specifically measure religious or spiritual constructs. Similarly, there are few existing studies that utilize standardized religious or spiritual measures with PNI outcome measures. Findings suggest that a body of knowledge now exists in support of interventions with mindfulness-breathing-stretching components; furthermore, these interventions appear to offer potential improvement or stabilization of neuroendocrine-immune activity in breast cancer survivors compared to control groups. Conclusion From a PNI perspective, future spiritually based interventions should include standardized measures of religiousness and spirituality in order to understand relationships between and among religiousness, spirituality, and neuroendocrine-immune outcomes. Future research should now focus on determining the minimum dose and duration needed to improve or stabilize neuroendocrine-immune function, as well as diverse setting needs, including home-based practice for survivors who are too ill to travel to group sessions or lack economic resources.Entities:
Keywords: breast cancer; interventions; oncology; psychoneuroimmunology; religious; review; spirituality
Mesh:
Year: 2016 PMID: 27151592 PMCID: PMC5125023 DOI: 10.1177/1534735416636222
Source DB: PubMed Journal: Integr Cancer Ther ISSN: 1534-7354 Impact factor: 3.279
Figure 1.Flowchart of article identification, screening, and selection process.
Spiritually Based Interventions and Psychosocial-Spiritual Outcomes in Breast Cancer Survivors.
| Study Number (See | Spiritually Based Interventions | Psychosocial-Spiritual Outcomes (↓ or ↑)[ |
|---|---|---|
| 1,4, 6, 8, 15, 18 | CBSM, MBSR, Qigong, RVT, Yoga | ↓ Depression |
| 1, 4, 6, 8, 12 | CBSM, MBSR, RVT, Yoga | ↓ Anxiety |
| 2, 4, 14, 15, 18, 19, 20 | MBCR, MBSR, Qigong, Yoga | ↑ Quality of life/vitality/vigor |
| 4 | Yoga | ↓ Distress |
| 4, 17 | MBSR, Yoga | ↓ Symptoms |
| 2 | MBSR | ↑ Coping |
| 5, 7 | CBSM | ↑ Relaxation |
| 1, 6, 8, 12, 14, 18 | CBSM, MBCR, MBSR,RVT, Yoga | ↓ Stress |
| 16 | Tai Chi | ↑ Stress |
| 9, 12, 13 | MBSR | ↑ Mindfulness |
| 11 | BMS | ↑ Spiritual growth/spiritual well-being |
| 13 | MBSR | ↓ Rumination |
| 14 | MBCR | ↑ Social support |
| 15, 17, 18, 19, 20 | MBSR, Qigong, Stretching, Yoga | ↓ Fatigue |
| 9, 14 | MBCR, MBSR | ↑ Mood |
| 17 | MBSR | ↑ Cognitive function (postchemotherapy) |
Abbreviations: CBSM, cognitive-based stress management; MBCR, mindfulness-based cancer recovery; MBSR, mindfulness-based stress reduction; RVT, relaxation visualization therapy; BMS, body-mind-spirit.
↓ indicates decreased and ↑ indicates increased.
RS Interventions and Biomarker Outcomes in Breast Cancer Survivors.
| Study Number (See | RS Intervention | Biomarker Outcomes (↓, ↑, or Stable)[ |
|---|---|---|
| 18 | Yoga | ↓ Interleukin (IL)-1 |
| 7, 20 | GI, Yoga | ↓ IL-1β |
| 3, 6 | GI, CBSM | ↑ (IL)-2 |
| 2, 17 | MBSR | ↓ IL-4 |
| 6 | CBSM | ↑ IL-4 |
| 2, 20 | MBSR, Yoga | ↓ IL-6 |
| 2 | MBSR | ↓ IL-10 |
| 2, 3, 7 | GI, MBSR | ↑Natural killer (NK) cell activity |
| 4 | Yoga | ↓ Immunoglobulin A (IgA) |
| 4 | Yoga | ↑ CD56 % |
| 2, 5, 6, 8, 9[ | BMS, CBSM, MBCR, MBSR,Yoga | ↓ Cortisol |
| 1, 12, 15, 18 | MBSR, Qigong, RVT, Yoga | Stable or no change in cortisol |
| 18, 20 | Yoga | Stable or ↓ tumor necrosis factor–α (TNF-α) |
| 9, 13 | MBSR | ↓ Blood pressure |
| 9 | MBSR | ↓ Pulse |
| 9 | MBSR | ↓ Respirations |
| 2, 6, 10, 17 | CBSM, MBSR | ↑ Lymphocyte subsets; T cells, Th1/Th2 |
| 7, 17 | GI, MBSR | ↑ CD4+/CD8+ |
| 2, 6, 17 | CBSM, MBSR | ↑ Interferon-γ (IFN-γ) |
| 21, 22 | MBSR | Stable (preserved) telomere length |
| 17 | MBSR | Stable/no change in CD4+ T lymphocytes |
| 17 | MBSR | Stable/no change CD3+ subsets (T1/T2) |
Abbreviations: RS, religious and spiritual; GI, guided imagery; CBSM, cognitive-based stress management; MBSR, mindfulness-based stress reduction; BMS, body-mind-spirit; RVT, relaxation/visualization therapy; MBCR, mindfulness-based cancer recovery.
↓ indicates decreased and ↑ indicates increased.
Decreased cortisol not sustained at 1 month follow-up.
RS Interventions With PNI Measures in Breast Cancer Survivors.
| No. | Study (First Author, Year) | Design | Cancer Stage | Intervention Group (IG) (n) vs Control Group (CG) (n) | Intervention Duration | Psychosocial and RS Measures | Objective (PNI) Measures | Key Health Outcomes |
|---|---|---|---|---|---|---|---|---|
| 1 | Nunes (2007)[ | RCT | I-II | Relaxation/visualization (IG) (RVT)* (n = 20) | 24 consecutive days, 30-min sessions | Stress, Anxiety, Depression (ISSL, STAI, BAI, BDI) | Cortisol | RVT improved depression and anxiety scores ( |
| 2 | Witek-Janusek (2008)[ | Non-RCT | 0-II | MBSR (IG) (n = 38) | 8 weeks; 150 min/wk | Quality of Life, Coping, Mindfulness (QOLI-cv3, JCS, MAAS) | Lymphocytes, NKCA, Cytokines (Interleukin [IL])-2, IL-4, IL-6, IL-10, and interferon-gamma (IFN-γ), cortisol | MBSR group had lower levels of NKCA, IL-4, IL-6, IFN-γ (all |
| 3 | Lengacher (2008)[ | RCT | 0-II | Guided imagery (IG) (n = 15) | 6-7 weeks (2-3 weeks preop through 4 weeks postop) | None | Natural killer (NK) cells, cytokine (IL-2) | Guided imagery positively influenced NK cell cytotoxicity after IL-2 activation at 4 weeks postoperative compared with CG ( |
| 4 | Rao (2008)[ | RCT | II-III | Yoga (IG) (n = 33) | 4 weeks | (Anxiety, Depression, Function) | T-lymphocyte subsets, CD4%, CD8%, NK cells, and immunoglobulin (IgA, IgG, IgM) | Yoga group demonstrated decreased anxiety ( |
| 5 | Phillips (2008)[ | RCT | 0-III | CBSM (IG) (n = 65) | 10 weeks; repeat measures over 12 months | Current Status (MOCS-Relaxation) | Cortisol | Greater reductions in cortisol levels across 12 months in CBSM compared with CG, although effect was small ( |
| 6 | Antoni (2009)[ | RCT | 0-III | CBSM (IG) (n = 65) | 10 weeks | Stress, Anxiety & Depression, & Negative Mood | Cortisol, lymphocyte subsets, cytokines (IL-2, IFN-γ, IL-4) | CBSM had improved cortisol patterns ( |
| 7 | Eremin (2009)[ | RCT | II-IV | Relaxation and guided imagery (IG) (n = 40) | 37 weeks | None | T-cell subsets and lymphokine activated killer cells, B lymphocytes and monocytes; cytokines IL-1beta (1β), IL-2, IL-4 and IL- 6 and TNF-α | At 8 weeks, significant correlations observed between imaging ratings and natural killer cell activity ( |
| 8 | Vadiraja (2009)[ | RCT | I-III | Yoga (IG) (n = 44)* | 6 weeks | Anxiety & Depression, Stress | Cortisol | Positive correlations between decreased AM cortisol levels and decreased anxiety (Cohen’s |
| 9 | Matchim (2010)[ | Non-RCT | 0-II | MBSR (IG) (n = 15) | 8 weeks | Mood, Stress, Mindfulness (POMS, C-SOSI, FFMQ) | Salivary cortisol, blood pressure (BP), pulse, and respirations | Increased mindfulness decreased BP, pulse, and respirations observed in MBSR compared with CG ( |
| 10 | Lengacher (2013)[ | RCT | 0-III | MBSR (IG) (n = 42) | 6 weeks | None | Lymphocyte subsets, T helper 1 and 2 cells (Th1/Th2), NK cells, IFN-γ, IL-4 | Positive associations between all immune subset recoveries in MBSR group compared with CG. Women who received MBSR had T cells more readily activated by the mitogen phytohemagglutinin and an increase in the Th1/Th2 ratio ( |
| 11 | Hsiao (2012)[ | RCT | 0-III | Body-mind-spirit (BMS) (IG) (n = 26) | 8 weeks | Depression Meaning in Life | Cortisol | At 5 months, BMS was related to greater spiritual growth (search for meaning in life) ( |
| 12 | Branstrom (2012; 2013)[ | RCT | Data not provided | MBSR (IG) (n = 32) | 8 weeks | Stress, Anxiety & Depression, Mood, Coping; Mindfulness | Cortisol | MBSR associated with lower stress ( |
| 13 | Campbell (2012)[ | NonRCT | Data not provided | MBSR (IG) (n = 19) | 8 weeks | Mindfulness, Rumination (MAAS, RRQ-rs) | Blood pressure (BP) | MBSR may improve mindfulness, moderate effect between decreased rumination and decrease systolic BP ( |
| 14 | Carlson (2013)[ | RCT | 0-IV | MBCR (IG) (n = 113) | 8 weeks | Mood, Stress, Quality of Life, Social Support | Cortisol | Cortisol patterns were stable over time in both SET ( |
| 15 | Chen (2013)[ | RCT | 0-III | Qigong (IG) (n = 49)* | 5 weeks | Depression, Fatigue, Quality of Life, Sleep Disturbance | Cortisol | Qigong group reported less depression over time than women in CG ( |
| 16 | Robins (2013)[ | RCT | I-IIIa | (n = 109)* (no further data) | 10 weeks | Stress, Quality of Life, Depression | Cytokine panel (IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12, IL-13, IL-17, TNF-α) | Interesting patterns in biomarkers observed; however, no statistically significant effects observed between intervention and control groups while |
| 17 | Reich (2014)[ | RCT | 0-III | MBSR (IG) (n = 17) | 6 weeks | Symptoms | Lymphocyte subsets, mitogen-stimulated subsets, cytokines | After 6 weeks, multiple baseline biomarkers were significantly positively improvement in GI symptoms ( |
| 18 | Bower (2012; 2014)[ | RCT | 0-II | Iyengar yoga (IG) (n = 14) | 12 weeks | Fatigue, Depression, Sleep, Stress, Vigor | Cortisol, tumor necrosis factor-alpha (TNF-α), IL-1, IL-6, CRP | Decreased fatigue in yoga group from baseline to posttreatment and sustained at 3-month follow-up compared to CG ( |
| 19 | Chandwani (2014)[ | RCT | 0-III | Yoga (IG) (n = 53)* | 6 weeks | Quality of Life, Fatigue, Depression, Sleep | Cortisol | Yoga group demonstrated greater increases in physical component scale scores compared with CG at 1 and 3 months after radiotherapy ( |
| 20 | Kiecolt-Glaser (2014)[ | RCT | 0-IIIa | Yoga (IG) (n = 100) | 12 weeks | Fatigue, Quality of Life, Depression, Sleep, Activity, Diet | Cytokines (IL-1β, IL-6, TNF-α) | At posttreatment, fatigue was not lower in yoga compared with CG ( |
| 21 | Lengacher (2014)[ | RCT | 0-III | MBSR (IG) (n = 74) | 6 weeks intervention | Recurrence Concerns, Mindfulness, Stress, Anxiety, Depression | Telomere length, telomere activity | Telomere activity (TA) increased steadily over 12 weeks in MBSR group (17%) compared with minimal increase in CG (approximately 3%, |
| 22 | Carlson (2015)[ | RCT | I-III | MBCR (IG) (n = 53) | 8 weeks | Mood, Stress | Telomere length | No correlations between measures of mood ( |
Abbreviations: RS, religious and spiritual; PNI, psychoneuroimmunological; RCT, randomized control trial group; IG, intervention group; CRP, C-reactive protein; CG, control group; RVT, relaxation and visualization therapy; ISSL, Inventory of Stress Symptoms Lipp; STAI, State-Trait Anxiety Inventory; BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory; non-RCT, nonrandomized control trial group; MBSR, mindfulness-based stress reduction; QOLI-v3, Quality of Life Index Cancer Version 3, JCS, Jaloweic Coping Scale; MAAS, Mindfulness Attention Awareness Scale; FLIC, Functional Living Index of Cancer; MOCS-R, Measure of Current Status–Relaxation; IES, Impact of Events Scale; HADS, Hospital Anxiety and Depression Scale; ABS, Affects Balance Scale; PSS, Perceived Stress Scale; POMS, Profile of Mood States; C-SOSI, Calgary Symptoms of Stress Inventory; FFMQ, Five Facet Mindfulness Questionnaire; MDASI, MD Anderson Symptom Inventory; MLQ-P, Meaning in Life Questionnaire, Presence; MLQ-S, Meaning in Life Questionnaire; IES-R, Impact of Events Scale–Revised; PSOM, Positive State of Mind; CSES, Coping Self-Efficacy Scale; RRQ-rs, Rumination Reflection Questionnaire—revised; MBCR, mindfulness-based cancer recovery; POMS-TMD, Profile of Mood States–Total Mood Disturbance; FACT-B, Functional Assessment of Cancer Therapy–Breast; FACT-G, Functional Assessment of Cancer Therapy–General; MOS-SSS, Medical Outcomes Study–Social Support Survey; SOSI, Symptoms of Stress Inventory; NK, natural killer; IFN-γ, interferon-gamma; IL, interleukin; DHEA, dehydroepiandrosterone sulfate; FACIT-G, Functional Assessment of Cancer Illness Therapy–General; CES-D, Center for Epidemiological Studies–Depression Scale; BFI, Brief Fatigue Inventory; PSQI, Pittsburg Sleep Quality Index; FSI, Fatigue Symptom Inventory; BDI-II, Beck Depression Inventory–II; MFSI, Multidimensional Fatigue Symptom Inventory; MO SF-36, Medical Outcomes Short-Form 36; CHAMPS, Community Healthy Activities Model Program for Seniors; FFQ, Food Frequency Questionnaire; CARS, Concerns About Recurrence Scale; CAMS, Cognitive and Affective Mindfulness Scale–Revised.